These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 11826754)
1. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Chang TT; Kuchroo VK; Sharpe AH Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754 [No Abstract] [Full Text] [Related]
2. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741 [TBL] [Abstract][Full Text] [Related]
3. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409 [TBL] [Abstract][Full Text] [Related]
4. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eagar TN; Karandikar NJ; Bluestone JA; Miller SD Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563 [TBL] [Abstract][Full Text] [Related]
5. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Salomon B; Bluestone JA Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036 [TBL] [Abstract][Full Text] [Related]
6. Blockade of costimulatory molecules on dendritic cells: implications for tolerance induction. Luke PP; Thomson AW Transplant Proc; 2001; 33(1-2):507-8. PubMed ID: 11266929 [No Abstract] [Full Text] [Related]
7. The expanding world of co-stimulation: the two-signal model revisited. Chambers CA Trends Immunol; 2001 Apr; 22(4):217-23. PubMed ID: 11274928 [TBL] [Abstract][Full Text] [Related]
8. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. Karandikar NJ; Vanderlugt CL; Bluestone JA; Miller SD J Neuroimmunol; 1998 Aug; 89(1-2):10-8. PubMed ID: 9726820 [TBL] [Abstract][Full Text] [Related]
9. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867 [TBL] [Abstract][Full Text] [Related]
10. The ups and downs of T cell costimulation. Jenkins MK Immunity; 1994 Sep; 1(6):443-6. PubMed ID: 7534615 [No Abstract] [Full Text] [Related]
11. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. Broeren CP; Gray GS; Carreno BM; June CH J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816 [TBL] [Abstract][Full Text] [Related]
12. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). Mandelbrot DA; McAdam AJ; Sharpe AH J Exp Med; 1999 Jan; 189(2):435-40. PubMed ID: 9892625 [TBL] [Abstract][Full Text] [Related]
13. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis. Perrin PJ; Scott D; June CH; Racke MK Immunol Res; 1995; 14(3):189-99. PubMed ID: 8778209 [TBL] [Abstract][Full Text] [Related]
17. New protein steals the show as 'costimulator' of T cells. Cohen J Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360 [No Abstract] [Full Text] [Related]
18. The interaction properties of costimulatory molecules revisited. Collins AV; Brodie DW; Gilbert RJ; Iaboni A; Manso-Sancho R; Walse B; Stuart DI; van der Merwe PA; Davis SJ Immunity; 2002 Aug; 17(2):201-10. PubMed ID: 12196291 [TBL] [Abstract][Full Text] [Related]